| 摘要 |
The invention relates to compositions and methods for the treatment of dry eye and related diseases utilizing 6-keto-PGF1 alpha and its analogs, according to formula (I); wherein A, B, D, Q<9>, Q<11>, R<1>, X and Y have the meanings given in the description. Some of these compounds are novel.
|
